2020
DOI: 10.1016/j.vaccine.2019.11.023
|View full text |Cite
|
Sign up to set email alerts
|

Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine, Vaccine Adverse Event Reporting System (VAERS), 2010–2017

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
105
1
3

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(110 citation statements)
references
References 27 publications
1
105
1
3
Order By: Relevance
“…The mechanism of injury was theorized to be related to the improper introduction of vaccine into the subdeltoid bursa, causing an inflammatory reaction leading to bursitis, tendonitis, and adhesive capsulitis (Macomb et al, 2020). Critically, the VICP does not limit the definition of SIRVA to those who have received the influenza vaccine, as several other vaccines have been reported to cause this condition (Atanasoff et al, 2010; Cross et al, 2016; HRSA, 2017; Hibbs et al, 2020). Given the likely inflammatory nature of this condition, we found that early administration of systemic or local glucocorticoids provided a benefit in most cases.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The mechanism of injury was theorized to be related to the improper introduction of vaccine into the subdeltoid bursa, causing an inflammatory reaction leading to bursitis, tendonitis, and adhesive capsulitis (Macomb et al, 2020). Critically, the VICP does not limit the definition of SIRVA to those who have received the influenza vaccine, as several other vaccines have been reported to cause this condition (Atanasoff et al, 2010; Cross et al, 2016; HRSA, 2017; Hibbs et al, 2020). Given the likely inflammatory nature of this condition, we found that early administration of systemic or local glucocorticoids provided a benefit in most cases.…”
Section: Discussionmentioning
confidence: 99%
“…While early treatment is important, SIRVA is a preventable condition if vaccine is administered properly. The CDC (2017) and others have created guidelines on proper vaccination techniques that are meant to prevent cases of SIRVA (Hibbs et al, 2020). These guidelines focus on utilizing the proper length of needle based on patient gender and body weight, as well as proper insertion point in the center of the deltoid muscle which can be estimated by inserting the needle 2 to 3 finger lengths below the acromion (about 2 inches).…”
Section: Discussionmentioning
confidence: 99%
“…In the same decade, only 112 cases of SIRVA have been adjudicated by the Office of Special Masters of the US Court of Federal Claims, with half of those cases occurring in the past two years [14]. The true incidence and prevalence in the United States of SIRVA are unclear as research has primarily been reported as isolated case series [15]. SIRVA symptoms mimic multiple neuromusculoskeletal pathologies such as cervical radiculopathy, rotator cuff strain, and adhesive capsulitis, which can lead to underdiagnosis and misdiagnosis [14,15].…”
Section: Discussionmentioning
confidence: 99%
“…The true incidence and prevalence in the United States of SIRVA are unclear as research has primarily been reported as isolated case series [15]. SIRVA symptoms mimic multiple neuromusculoskeletal pathologies such as cervical radiculopathy, rotator cuff strain, and adhesive capsulitis, which can lead to underdiagnosis and misdiagnosis [14,15]. Thorough clinical history and elicitation of the inciting event is critical diagnosing SIRVA.…”
Section: Discussionmentioning
confidence: 99%
“…To be eligible to file a VICP claim, symptoms must last more than 6 months after vaccination. [21] Based on the VICP SIRVA case definition and other publications, [1,8,12,22,23] we created a SIRVA case definition suitable for a population-based study using EHR data. A valid SIRVA case needed to meet five criteria: 1) Damage to the shoulder region occurred and was confirmed by signs and symptoms (i.e., pain, limited range of motion, weakness, stiffness) and clinical diagnosis.…”
Section: Sirva Case Definitionmentioning
confidence: 99%